Palisade Bio, Inc. · NASDAQ:PALI

Octagon Capital Advisors LP reported a 6.40% stake in Palisade Bio, Inc. (Schedule 13G)

Event Dec 31, 2025 · Filed Feb 10, 2026

Octagon Capital Advisors LP reported a 6.40% stake in Palisade Bio, Inc., 9,567,898 shares, as a passive investor on Dec 31, 2025. Filed Feb 10, 2026 (Schedule 13G).

Stake
6.40%
Shares
9,567,898
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Octagon Capital Advisors LP6.40%9,567,898
Octagon Investments Master Fund LP6.40%9,567,898
Ting Jia6.40%9,567,898

Source

View original at SEC

Related